Ying Hong, Tomoko Ishizuka, Akiko Watanabe, Masaya Tachibana, Mark Lee, Hitoshi Ishizuka, . . . Malaz Abutarif. (2021). Model‐based assessments of CYP3A‐mediated drug‐drug interaction risk of milademetan. Wiley.
Chicago Style (17th ed.) CitationYing Hong, Tomoko Ishizuka, Akiko Watanabe, Masaya Tachibana, Mark Lee, Hitoshi Ishizuka, Frank LaCreta, and Malaz Abutarif. Model‐based Assessments of CYP3A‐mediated Drug‐drug Interaction Risk of Milademetan. Wiley, 2021.
MLA (9th ed.) CitationYing Hong, et al. Model‐based Assessments of CYP3A‐mediated Drug‐drug Interaction Risk of Milademetan. Wiley, 2021.
Warning: These citations may not always be 100% accurate.